DAPAYES-M
Dapagliflozin 10 mg Tablet
-
Selectively inhibits SGLT2 in the renal proximal tubule
-
Lowers glycemia independently of B-cell function and insulin resistance
-
Induces urinary glucose excretion, resulting in a reduction of blood glucose
-
Beyond HbA1c- It offers
-
Weight reduction
-
Blood pressure reduction
-
Risks/Limitations : eGFR > 45-60 ml/min vate Windows
-
Reduced the risk of CV death or heart failure hospitalization